The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 07, 2021

Filed:

Feb. 05, 2016
Applicants:

Kolon Life Science, Inc., Seoul, KR;

Tissuegene, Inc., Rockville, MD (US);

Inventors:

Heonsik Choi, Seoul, KR;

Kyoungbaek Choi, Incheon, KR;

Hyeonyoul Lee, Gyeonggi-do, KR;

Daewook Kim, Gyeonggi-do, KR;

Hyesun Lee, Seoul, KR;

Min Kim, Seoul, KR;

Sujeong Kim, Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/32 (2015.01); A61P 29/00 (2006.01); A61K 35/12 (2015.01); A61P 3/10 (2006.01); A61P 19/02 (2006.01); A61K 38/18 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/32 (2013.01); A61K 35/12 (2013.01); A61K 38/1841 (2013.01); A61P 3/10 (2018.01); A61P 19/02 (2018.01); A61P 29/00 (2018.01); A61K 48/00 (2013.01);
Abstract

Provided is a cell therapeutic agent for treating an inflammatory disease induced by a hyperimmune response, more specifically, a composition for treating an inflammatory disease induced by a hyperimmune response, which comprises (i) a chondrocyte or a cell capable of differentiating into a chondrocyte; and (ii) a cell into which a gene encoding TGF-β is introduced, wherein the cell in (ii) is derived from human embryonic kidney 293 (HEK-293) cell.


Find Patent Forward Citations

Loading…